Riskpilot← Back to searchSign inGet full accessNEC ONCOIMMUNITY AS
ASActiveOrg 913062612Ullernchausséen 64, 0379 OsloComputer programming activities · NACE 6210Est. 201432 employees
Revenue 2025
NOK 45,9M
-37% vs 2024
EBITDA margin
-142.3%
-48% vs 2024
Equity ratio
60.6%
Financial strength
Net profit 2025
NOK -67,9M
-51% vs 2024
| Revenue | NOK 45,9M | -37% |
| EBITDA | NOK -65,3M | -48% |
| Net profit | NOK -67,9M | -51% |
| Total assets | NOK 73M | -17% |
| Equity | NOK 44,2M | -3% |
| Employees | 32 | — |
Legal name
NEC ONCOIMMUNITY AS
Org number
913062612
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
14. januar 2014
Share capital
NOK 465 654
Employees
32 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Forske på, utvikle, kommersialisere og selge metoder, tjenester og produkter innen medisinsk programvare. Formålet kan fremmes gjennom deltagelse i eller samarbeid med andre virksomheter i norge og i utlandet, samt gjennom konsulentvirksomhet.
Address
Ullernchausséen 64, 0379 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 17 552 | 11 610 | 26 460 | 73 315 | 45 893 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −20 617 | −24 269 | −34 614 | −44 039 | −65 287 |
| Depreciation & amort. | −135 | −109 | −1 982 | −2 057 | −2 285 |
| EBIT | −20 753 | −24 378 | −36 597 | −46 096 | −67 571 |
| Net financials | −540 | 154 | 203 | 1 097 | −322 |
| Profit before tax | −21 292 | −24 225 | −36 394 | −44 999 | −67 893 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −21 292 | −24 225 | −36 394 | −44 999 | −67 893 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 37 961 | 132 303 | 73 046 | 87 807 | 73 048 |
| Equity | 21 278 | 97 054 | 60 660 | 45 660 | 44 244 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 16 683 | 35 250 | 12 386 | 42 146 | 28 804 |
| Total debt | 16 683 | 35 250 | 12 386 | 42 146 | 28 804 |
EBITDA margin
-142.3%
This company
15.8%
Market median
-1001% vs market
20212025
Equity ratio
60.6%
This company
38.2%
Market median
+59% vs market
20212025
Return on equity
-153.5%
This company
18.4%
Market median
-934% vs market
20212025
Net profit margin
-147.9%
This company
8.1%
Market median
-1926% vs market
20212025
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20212025
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SN Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
RN Chief Executive Officer | Chief Executive Officer | 2016 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nec Bio Bv | Company | 100% | 100% | 2024 |
| Individual | 96.68% | 96.68% | 2022 | |
| Company | 1.66% | 1.66% | 2022 | |
| Company | 1.66% | 1.66% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEC ONCOIMMUNITY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Nicholas John Stratford | Chief Executive Officer | 0 companies |
| Saverio Niccolini | Chief Executive Officer | 0 companies |
| Akira Kitamura | Chairman | 0 companies |
| Jürgen Wilhelm Quittek | Board of Directors | 0 companies |
| Tomoki Kubo | Board of Directors | 0 companies |
| Angelo Binetti | Board of Directors | 0 companies |
| Trevor Clancy | Board of Directors | 0 companies |
| Naoko Yamagata | Board of Directors | 0 companies |
| Tomoyuki Takaoka | Board of Directors | 0 companies |